Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC)

Céline Boschi (1, 2) , Philippe Colson (1, 2) , Audrey Bancod (1, 2) , Valérie Moal (1, 2) , Bernard La Scola (1, 2)

1 MEPHI - Microbes évolution phylogénie et infections
2 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection

Domaines: Bactériologie; Virologie; Parasitologie; Cardiologie et système cardiovasculaire; Maladies émergentes; Maladies infectieuses

Céline Boschi, Philippe Colson, Audrey Bancod, Valérie Moal, Bernard La Scola. Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC). Clinical Infectious Diseases, 2022, ⟨10.1093/cid/ciac143⟩. ⟨hal-03683548⟩